UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3434

2022

Volltextzugriff (PDF)

Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL

Immunology, 2017-12, Vol.152 (4), p.562-573

2017

Volltextzugriff (PDF)

EBV counteracts IL‐21‐induced apoptosis in an EBV‐positive diffuse large B‐cell lymphoma cell line

International journal of cancer, 2013-08, Vol.133 (3), p.766-770

2013

Volltextzugriff (PDF)

Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection

Immunology, 2009-08, Vol.127 (4), p.549-557

2009

Volltextzugriff (PDF)

Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells

Immunology, 2006-03, Vol.117 (3), p.379-385

2006

Volltextzugriff (PDF)

B‐lymphocyte subpopulations are equally susceptible to Epstein–Barr virus infection, irrespective of immunoglobulin isotype expression

Immunology, 2003-04, Vol.108 (4), p.427-430

2003

Volltextzugriff (PDF)

Expression of the chemokine receptors CCR1 and CCR2B is up-regulated in peripheral blood B cells upon EBV infection and in established lymphoblastoid cell lines

Virology (New York, N.Y.), 2017-12, Vol.512, p.1-7

2017

Volltextzugriff (PDF)

EBV‐encoded EBNA‐5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF‐expressing cells

International journal of cancer, 2003-07, Vol.105 (5), p.644-653

2003

Volltextzugriff (PDF)

CD40 ligation downregulates EBNA‐2 and LMP‐1 expression in EBV‐transformed lymphoblastoid cell lines

International journal of cancer, 2002-06, Vol.99 (5), p.705-712

2002

Volltextzugriff (PDF)

Epstein‐Barr virus genomes are found predominantly in IgA‐positive B cells in the blood of healthy carriers

International journal of cancer, 1999-09, Vol.83 (1), p.50-54

1999

Volltextzugriff (PDF)

EBNA promoter usage in ebv‐negative burkitt lymphoma cell lines converted with a neomycin‐resistant EBV strain

International journal of cancer, 2001-09, Vol.93 (5), p.714-719

2001

Volltextzugriff (PDF)

Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ￂ DLBCL

Immunology, 2017-12, Vol.152 (4), p.562

2017

Volltextzugriff (PDF)

Scavenger Receptors Mediate Adhesion of Activated B Lymphocytes

Experimental cell research, 1998-02, Vol.239 (1), p.16-22

1998

Volltextzugriff (PDF)

Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line [published erratum appears in J Gen Virol 1998 Nov;79(Pt 11):2875]

Journal of general virology, 1998-06, Vol.79 (6), p.1445-1452

1998

Volltextzugriff (PDF)

Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes

Molecular medicine (Cambridge, Mass.), 1995-07, Vol.1 (5), p.495-505

1995

Volltextzugriff (PDF)

B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespection, irrespective of immunoglobulin isotype expression

Immunology, 2003-04, Vol.108 (4), p.427

2003

Volltextzugriff (PDF)

Epstein-Barr virus susceptibility of normal human B lymphocyte populations

The Journal of experimental medicine, 1984, Vol.159 (1), p.208-220

1984

Volltextzugriff (PDF)

Correlation between the growth‐inhibitory effect of TGF‐β1 and phenotypic characteristics in a panel of B‐cell lines

International journal of cancer, 1993-08, Vol.55 (1), p.137-140

1993

Volltextzugriff (PDF)

A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes

Cancer Immunology Immunotherapy, 1985-08, Vol.20 (1), p.23-28

1985

Volltextzugriff (PDF)

Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection

Journal of Virology, 1990-11, Vol.64 (11), p.5441-5447

1990

Volltextzugriff (PDF)

Antibodies against a Synthetic Peptide Identify the Epstein--Barr Virus-Determined Nuclear Antigen

Proceedings of the National Academy of Sciences - PNAS, 1984-08, Vol.81 (15), p.4652-4656

1984

Volltextzugriff (PDF)

Expression of B‐cell‐specific markers in different burkitt lymphoma subgroups

International journal of cancer, 1987-02, Vol.39 (2), p.211-218

1987

Volltextzugriff (PDF)

Distinction between burkitt lymphoma subgroups by monoclonal antibodies: Relationships between antigen expression and type of chromosomal translocation

International journal of cancer, 1984-04, Vol.33 (4), p.459-463

1984

Volltextzugriff (PDF)

Characterization of a second Epstein‐Barr virus‐determined nuclear antigen associated with the BamHI WYH region of EBV DNA

International journal of cancer, 1985-03, Vol.35 (3), p.359-366

1985

Volltextzugriff (PDF)

Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis

International journal of cancer, 1985-02, Vol.35 (2), p.251-256

1985

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Biological And Medical Sciences
(19)
B-Lymphocytes - Immunology
(15)
Oncology
(15)
Cell Line
(14)
Medicin Och Hälsovetenskap
(14)
Epstein-Barr Virus
(12)
Medical Sciences
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Herpesvirus 4, Human - Genetics
(9)
Immunology
(9)
B-Lymphocytes - Virology
(7)
Burkitt Lymphoma - Immunology
(7)
Virology
(7)
Cell Transformation, Viral
(6)
Cells, Cultured
(6)
Ebv
(6)
Herpesvirus 4, Human - Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2

Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL

EBV counteracts IL‐21‐induced apoptosis in an EBV‐positive diffuse large B‐cell lymphoma cell line

Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection

Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells

B‐lymphocyte subpopulations are equally susceptible to Epstein–Barr virus infection, irrespective of immunoglobulin isotype expression

Expression of the chemokine receptors CCR1 and CCR2B is up-regulated in peripheral blood B cells upon EBV infection and in established lymphoblastoid cell lines

EBV‐encoded EBNA‐5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF‐expressing cells

CD40 ligation downregulates EBNA‐2 and LMP‐1 expression in EBV‐transformed lymphoblastoid cell lines

Epstein‐Barr virus genomes are found predominantly in IgA‐positive B cells in the blood of healthy carriers

EBNA promoter usage in ebv‐negative burkitt lymphoma cell lines converted with a neomycin‐resistant EBV strain

Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ￂ DLBCL

Scavenger Receptors Mediate Adhesion of Activated B Lymphocytes

Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line [published erratum appears in J Gen Virol 1998 Nov;79(Pt 11):2875]

Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes

B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespection, irrespective of immunoglobulin isotype expression

Epstein-Barr virus susceptibility of normal human B lymphocyte populations

Correlation between the growth‐inhibitory effect of TGF‐β1 and phenotypic characteristics in a panel of B‐cell lines

A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes

Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection

Antibodies against a Synthetic Peptide Identify the Epstein--Barr Virus-Determined Nuclear Antigen

Expression of B‐cell‐specific markers in different burkitt lymphoma subgroups

Distinction between burkitt lymphoma subgroups by monoclonal antibodies: Relationships between antigen expression and type of chromosomal translocation

Characterization of a second Epstein‐Barr virus‐determined nuclear antigen associated with the BamHI WYH region of EBV DNA

Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis

Suchergebnisse filtern